Hereditary angioedema (HAE) is a rare genetic disorder ... HAE is not typically accompanied by itchiness. In most cases, symptoms of HAE begin during childhood or early adolescence, typically ...

The following is a summary of “Comorbidities in Canadian patients with hereditary angioedema: a quantitative survey study,” ...

Patients with hereditary angioedema whose attacks impacted their larynx experienced on-demand relief within 1.29 hours with ...

KalVista Pharmaceuticals has finished enrolling subjects in its KONFIDENT-KID trial of sebetralstat for hereditary angioedema ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the completion of enrollment in the open-label KONFIDENT-KID ...

Hereditary angioedema (HAE) is a rare genetic disorder ... Food triggers were associated with abdominal symptoms or swelling of the face, throat, extremities, or genitals. In both studies ...

Symptoms affecting your nervous system, including seizures, are also common in people with HAE. One study of people with HAE found that around 17% have epilepsy. Hereditary angioedema and dental ...

CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

Effectiveness of Sebetralstat for the On-demand Treatment of Laryngeal Hereditary Angioedema Attacks: Interim Analysis from KONFIDENT-S was presented by Jonathan Bernstein, MD, FAAAAI, Professor ...